Post-Graduate Hematology / Oncology Translational (PG-HOT) Training Program at University of Cincinnati College of Medicine (UC COM) / Cincinnati Children’s Hospital Medical Center (CCHMC), will have NCI-supported postdoctoral fellowship positions available beginning in July 2021. PG-HOT’s objective is to train cancer researchers uniquely able to rapidly translate new discoveries into cancer patient care. Specific goals are to (1) Provide formal and integrated instruction on the role of intellectual property protection in drug development in the context of a complex economy that is both market-based and government-regulated; (2) Provide comprehensive didactic and practical training in anti-cancer compound evaluation, with a primary focus how to conceptualize, design, manage, and successfully carry to completion a clinical trial involving a novel drug; (3) Establish a collaborative structure that fosters creative and productive interactions between PhD scientists and MD-MD / PhD clinicians. Our T32-supported fellowship positions are available for up to 2 years; annual reappointment is contingent on adequate programmatic progress with at least 80% effort committed to a wet-lab research project carried out in an NIH-funded, cancer-focused laboratory at UC COM or CCHMC.
UC COM is strongly committed to diversity (www.uc.edu/about/equity-inclusion.html); in the 2022 edition of the U.S. News & World Report “Best Graduate School” rankings, UC COM came in at 17th in a brand-new diversity index. Interested candidates are invited to contact Dr. Vladimir Bogdanov, Program Director, at email@example.com for further details and the list of PG-HOT’s primary training faculty.
The University of Cincinnati is an Affirmative Action / Equal Opportunity Employer / Minority / Female / Disability / Veteran.